We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Your guide to a disrupted world
Add this topic to your myFT Digest for news straight to your inbox
National inn chains suffer as new lockdown policy heralds more pub closures
There are plenty of discoveries to bring to market but domestic funding has been squeezed
Carmaker has issued a type of debt that signals a company teetering on the edge
Former star fund manager disposes of 142m shares in FTSE 250 group for around £76m
Listed investment company says sentiment hit by difficulties at manager’s flagship fund
Fast-growing UK biotech will build factory to meet demand for gene sequencing machines
The argument that the fund manager’s chosen stocks are cheap is hard to sustain
IP Group’s “increased value” bid is actually a 2 per cent discount to net assets
John Varley faces prosecution not for bringing down a bank — but trying to save one
Neither group has quite scored as investors have hoped
Merger would create a £1.3bn leader in intellectual property commercialisation
No laughing matter for minority investors
Fund managers Neil Woodford and Mark Barnett are heavily invested in the IP company
Start-ups tap homegrown capital rather than going stateside
Aim-listed specialist investor operates a dual strategy
PureTech Health’s float comes as momentum grows in UK’s life science investment
Investment company closes in on one of Europe’s biggest biotech flotations
Two of its treatments are to start clinical trials next year
You can find good assets relatively cheaply by looking in the labs at the world’s top universities
Investors need patience as well as tolerance of risks
International Edition
